GenSol Diagnostics is a biotechnology startup that focuses on providing Fast, Accurate, and Affordable Canine DNA Testing. Utilizing state-of-the-art technology, the company offers genetic testing for various disorders in canines, aiding in healthy breeding practices and preventive wellness planning. With over 15 years of experience, GenSol Diagnostics ensures scientifically proven, non-invasive testing methods, with rapid 24 to 48-hour result turnaround time. Their comprehensive tests cover a range of genetic disorders and color/coat variations. The company's dedication to professional and accurate service has positioned them as a reliable resource in the biotechnology and healthcare industries. Although specific information regarding the headquarter and recent investment is not available, the company's commitment to providing accessible diagnostic solutions for canine health presents an intriguing opportunity for potential investors in the pet healthcare sector.
There is no investment information
No recent news or press coverage available for GenSol Diagnostics.